Forty-four patients (46 hips) with infected total hip arthroplasties were evaluated. They were entered into a protocol that included resection arthroplasty, six weeks of intravenous antibiotics which obtained a minimum postpeak serum bactericidal titer of 1:8, and possible reimplantation. Thirty-two of 46 hips (70%) were reimplanted. At an average of 40 months (range, 24-74 months) after reimplantation, infection recurred in three hips (9%). In two of the three recurrent infections, 1% bactericidal titers were not attained. Both of these hips were infected with gram-negative organisms. Minimum postpeak serum bactericidal titers of 1% were attained in 28 of 32 hips that were reimplanted, and only one of these hips (4%) had a recurrent infection (p = 0.035). The presence of retained cement after resection arthroplasty (ten hips) was not associated with recurrent infection. Fourteen hips (12 patients) were not reimplanted as a result of a combination of factors, including inadequate bone stock, poor soft-tissue quality, and antibiotic resistance of the infecting organism. The treatment of an infected total hip arthroplasty with resection arthroplasty, six weeks of intravenous antibiotics that attains a minimum postpeak serum bactericidal titer of 1:8, and reimplantation can be an effective and safe treatment.
Forty-four patients (46 hips) with infected total hip arthroplasties were evaluated. They were entered into a protocol that included resection arthroplasty, six weeks of intravenous antibiotics which obtained a minimum postpeak serum bactericidal titer of 1:8, and possible reimplantation. Thirty-two of 46 hips (70%) were reimplanted. At an average of 40 months (range, 24-74 months) after reimplantation, infection recurred in three hips (9%). In two of the three recurrent infections, 1% bactericidal titers were not attained. Both of these hips were infected with gram-negative organisms. Minimum postpeak serum bactericidal titers of 1% were attained in 28 of 32 hips that were reimplanted, and only one of these hips (4%) had a recurrent infection (p = 0.035). The presence of retained cement after resection arthroplasty (ten hips) was not associated with recurrent infection. Fourteen hips (12 patients) were not reimplanted as a result of a combination of factors, including inadequate bone stock, poor soft-tissue quality, and antibiotic resistance of the infecting organism. The treatment of an infected total hip arthroplasty with resection arthroplasty, six weeks of intravenous antibiotics that attains a minimum postpeak serum bactericidal titer of 1:8, and reimplantation can be an effective and safe treatment.
ing the past two decades. As a result of increased understanding of the pathophysiology of infections in conjunction with improved surgical techniques and the careful selection of appropriate antibiotics, successful reimplantation is now possible. Some European authors report good results with single-stage reimplantati~n.~'~,'~ However, at the present time, most American surgeons favor two-stage reimplantation, especially if the hip is infected with a virulent organism. Recent reports in the literature have documented success rates of 86 to 95% with a two-stage reimplantation protocol. 5,6,10~12, 1 These studies only evaluated the patients who were actually reimplanted. They did not include patients who started a protocol but could not be reimplanted. The purpose of this study is to report on all patients in the authors' institution with infected THAs who were started on a protocol consisting of resection arthroplasty followed by six weeks of quantitatively standardized intravenous antibiotics with possible reimplantation. The goal of the study was not only to determine the success of a two-stage reimplantation protocol, but to determine which factors were associated with recurrent infection or the abandonment of the reimplantation of a new
The treatment for infected total hip arthroplasty (THA) has improved significantly dur-Lieberman et al.
and Related Research tocol that included resection arthroplasty and six weeks of intravenous antibiotics in doses sufficient to attain a postpeak serum bactericidal titer (SBT) of at least 1.8. A tube dilution technique was employed in which the serum bactericidal activity of the antibiotic against the patient's own infecting organism was determined. Postpeak serum specimens were drawn one, one and one-half, two, three, or six hours after the administration of antibiotics depending on whether the dosage frequency was every four, six, eight, 12, or 24 hours respectively. The serum samples were serially diluted from 1:2 to 1:2048. They were then added to the infecting organisms in culture. The SBT was the highest dilution of serum, killing 99% of the infecting organism.
A serum bactericidal level of 1 :8 or greater was considered adequate to eradicate the infection based on previous experience with treatment of the infected THA.','* The choice of drug and dosage was dependent on the quantitative sensitivity of the organism, with consideration given to the ability o f the drug to penetrate and kill (minimum bactericidal c~ncentration).~ The six weeks oftherapy were measured from the time that the prostheses and all foreign bodies were removed. The patients were treated by a single infectious disease consultant who selected the antibiotics and monitored the postpeak SBTs. Changes in the antibiotic regimen were made according to the results of the cultures and titers. After reimplantation, the patients received intravenous antibiotics until intraoperative cultures were reported negative.
The factors that were analyzed included the quantitative antibiotic susceptibility of the infecting microorganisms, the duration of antibiotic therapy, the interval between resection arthroplasty and reimplantation, the bone stock that remained after the resection arthroplasty, the influence of prior surgical procedures, and the effect of retained cement. The statistical evaluation was performed using the Fisher Exact Test, and a nonparametric rank sum test. Survivorship analysis was determined using the Kaplan Meier method.
There were 25 women and 22 men in the study, and the average age was 69 years (range, 32-89 years). There were 42 THAs, six bipolar hemiarthroplasties, and one Austin-Moore prosthesis that were infected. There were 46 cemented and three cementless arthroplasties. The infected hip was a primary hip arthroplasty in 37 cases and a revision arthroplasty in 12 cases. Three of the 12 hips had been revised twice.
The primary preoperative diagnoses were osteoarthrosis in 33 hips, rheumatoid arthritis in five, posttraumatic arthritis in four, subcapital hip fractures in three, congenital dysplasia of the hip in two, and avascular necrosis and ankylosing spondylitis in one hip each. The average interval from implantation of the index arthroplasty to prosthesis removal was 41 months (range, one to 186 months).
Of the 49 infected hips, 34 were reimplanted with a prosthetic hip arthroplasty (Group I). Of these, two were excluded from the study: one patient died of unrelated causes four months after the reimplantation and another patient with a well-fixed total hip prosthesis without signs of recurrent infection was lost to follow-up evaluation after 13 months.
Thus, Group I consisted of 32 patients (32 hips) with an average follow-up period of forty months (range, 24-75 months). The average age of these patients was 67 years (range, 32-89 years).
There were 13 patients (1 5 hips) who were not reimplanted after removal of an infected prosthetic hip arthroplasty (Group 11). One patient was excluded from the study because she died of cardiac complications several days after resection arthroplasty. There were three other patients who died with less than a two-year follow-up period, but in each case the decision had been made not to reimplant a new prosthesis and these patients were included in the study. Thus, Group I1 consisted of 12 patients ( 14 hips) who were left with a resection arthroplasty. The average follow-up period was 40 months (range, five to 72 months) and the average age was 72 years old (range, 4 1-86 years).
At the time of prosthesis removal, specimens were obtained from the penprosthetic tissues and synovial fluid for aerobic and anaerobic microbiologic analysis (Table I) . Of the 32 hips that were reimplanted, 2 1 were infected with a single organ- ism, five with two different strains of the same organism and six with at least two organisms. Seven (21%) of these hips were infected with a gramnegative organism. Of the 14 hips that were maintained as resection arthroplasties, eight were infected with a single organism and six were infected with more than one organism. Eight hips (57%) were infected with a gram-negative organism, including two Pseudomonas infections. There was a significantly greater number of infections with gram-negative organisms in the resection arthroplasty group (p = 0.038). There was no statistically significant difference in the ages of the patients, number of previous surgical procedures, and presence of retained cement between the two groups.
Of the 32 reimplanted hips, there were 30 cemented THAs, with one cementless and one cemented bipolar prosthesis. Trochanteric osteotomy was performed in 15 hips. Gentamicin-impregnated beads were implanted at the time of resection arthroplasty in four hips, and in 17 patients antibiotic-impregnated cement was used at the time of reimplantation (tobramycin in ten patients, gentamicin in six, and vancomycin in one). Five hips were reconstructed using acetabular allografts, and four of these allografts were used in conjunction with a Mueller ring.
The average duration of parenteral antibiotic therapy was 41 days (range, 20-49 days). A minimum SBT of 1 :8 was attained in 28 of the 32 hips that were reimplanted. Three patients did not receive a full six-week course of intravenous antibiotics: one patient developed severe diarrhea secondary to antibiotic therapy and the antibiotics were stopped after 20 days. The hip was infected with Staphylococcus epidermidis and the SBT was 1:16. The other two patients were also infected with S. epidermidis, and the antibiotics were stopped at three and four weeks, respectively, at the discretion of the surgeon, because the organisms were extremely sensitive to antibiotics. The SBTs were 1512 and 1:2048, respectively. In all three patients, the reimplantations were performed immediately after the cessation of antibiotic therapy and there have been no recurrent infections.
The average time to reimplantation of a new prosthesis was 62 days (range, 20 days to 32 months). Twenty-four of the 32 hips (75%) were reimplanted at approximately two months. In five patients, there were significant delays (range, five to 32 months) between resection arthroplasty and reimplantation for a variety of problems, including a sinus tract in one hip; multiple abscesses noted at resection arthroplasty in one hip; and necessity of a redebndement five weeks after prosthesis removal in one hip. A fourth hip required multiple debridements and a vastus lateralis flap to heal the wound. In the fifth patient, the hip was in-fected with both Enterobacter and Enterococcus, and although SBTs of 1 : 16 were obtained for each organism, the reimplantation was delayed five months at the discretion of the surgeon. Infection recurred in the hip with multiple abscesses and the hip that required a vastus lateralis flap.
RESULTS
At an average follow-up interval of 40 months (range, 24 to 80 months), there have been three recurrent infections (9%) in the reimplantation group. There have been no revisions, and all hips were stable radiographically. There were two recurrences despite the use of antibiotic-impregnated cement and significant delays in reimplantation. One patient was a 53-year-old woman infected with Enterobacter cloacae, Enterococcus, and Staphylococcus aureus. The SBTs for the Enterobacter and the Enterococcus were less than 1 :8. Multiple debridements and a vastus lateralis flap were needed to heal the wound. Although reimplantation was delayed 32 months, the hip has intermittent episodes of recurrent drainage that have been treated with oral suppressive antibiotics. Although the hip had not been revised, at 26 months after surgery the patient has constant pain in the hip and a poor clinical result.
The second patient was a 65-year-old woman infected with S. aureus, in which multiple abscesses and a large amount of titanium debris were noted at prosthesis removal. Gentamicin beads were implanted at that time and the total hip prosthesis was reimplanted using gentamicin-impregnated cement five months later. Two months after reimplantation there was a recurrence of the S. aureus infection that responded to intravenous antibiotics and suppressive oral antibiotic therapy. The hip is well fixed radiographically and has not been revised at 70 months after reimplantation. The patient has no pain in the hip, ambulates unlimited distances without support, and has an excellent clinical result. The third recurrence was in an 80-year-old diabetic man who was infected with both Staphylococcus epidermidis and Klebsiella. Lieberman et al.
and Related Research
The new prosthesis was implanted with tobramycin-impregnated cement, but the postpeak SBT for the Klebsiella was only 1 :4 and a culture obtained at the time of reimplantation also grew out Klebsiella. The patient had recurrent drainage and was treated with redebridement and antibiotic suppression. After a 24-month follow-up period, the wound was dry and the prosthesis was well fixed radiographically. The patient resides in a nursing home because he has multiple medical problems and requires a walker to ambulate.
All three recurrent infections occurred less than one year after reimplantation. The probability of remaining free of recurrent infection after reimplantation based on survivorship analysis was 9 1 % at 60 months.
Two of the three recurrent infections occurred in patients where the SBTs were less than 1 9 . A minimum postpeak SBT of 1:8 was attained in 28 of 32 hips. A recurrent infection developed in only one of these 28 hips. In contrast, two of four hips with an inadequate postpeak SBT developed a recurrent infection. This difference was statistically significant 0, = 0.035). Other factors such as time to reimplantation, use of antibiotic impregnated cement, and previous surgical procedures were not statistically significant (r, = 0.12).
There were ten cases of retained femoral cement after resection arthroplasty. Six of the ten hips were infected with a gram-negative bacillus and/or multiple organisms. Seven were reimplanted without recurrence of infection. One patient was maintained on an oral antibiotic for one year. The other three were not reimplanted because of a combination of factors, including infection with multiple virulent organisms, severe acetabular defect, and patient refusal.
RESECTION ARTHROPLASTY
In 12 patients (14 hips), a decision was made not to perform a reimplantation ( Table  2 ). Five hips had at least one revision arthroplasty before infection. Three patients subsequently died, but a reimplantation was not planned in any of these hips. The average duration of intravenous antibiotic therapy in these 12 patients was 39 days (range, 20-44 days). One patient received only 20 days of therapy because of severe diarrhea. A minimum postpeak SBT of 1 :8 was attained in 12 of the 14 hips.
Five patients were left with resection arthroplasty because of severe acetabular bone loss. In four of these patients, the hip was infected with either multiple organisms or an antibiotic-resistant organism. Other reasons for not reimplanting a new hip prosthesis included a recurrent local infection, poor wound healing with prolonged (23 weeks) postoperative drainage, limited duration of antibiotic therapy secondary to diarrhea, inadequate antibiotic levels, a femoral fracture that required a femoral intramedullary rodding, three sacral decubitus ulcers, and limited rehabilitation expectations. Two patients with bilateral hip arthroplasties and an infection with multiple organisms in one hip eventually required bilateral resection arthroplasties because the contralateral hip became infected. In some patients, there were multiple reasons for avoiding reimplantation ( Table 2) .
One patient (7%) had a reinfection despite the resection arthroplasty. This patient was a 4 1 -year-old man infected with Pseudomonas who developed a streptococcal cellulitis two months after the resection arthroplasty, which responded well to intravenous antibiotic therapy. The patient had a recurrence secondary to Streptococcus two years later and was treated with oral antibiotics. The patient remains asymptomatic on antibiotic suppression, but there have been no subsequent problems after 73 months.
Of the 12 patients in the resection arthroplasty group, three have died, including one patient with bilateral resection arthroplasties who was confined to a wheelchair. Seven of the other nine patients were able to ambulate: three patients used a walker, three a cane, and one a crutch. Only one patient was able to ambulate more than six blocks. The other two patients were confined to wheelchairs. Five patients reported no pain or slight pain, and three patients had mild to moderate pain that required the use of antiinflammatory medications. One patient had serious limitations in activity as a result of the hip pain. The average Harris Hip Score in these patients was 56 points (range, 35-75 points).
In contrast, the patients in the reimplantation group were generally more active. Of the 32 patients in this group, 18 ambulated without support, ten used canes part time or full time, one used a crutch, and three used walkers. Twenty-four patients reported no pain or slight pain in the hip. Eight of the patients had mild or moderate pain that required the use of antiinflammatory medica-tions. The average Harris Hip Score was 75 points (range, 45-95 points).
COMPLICATIONS
Intraoperative complications that occurred during resection arthroplasty usually were related to cement removal. There were four femoral perforations and two femoral fractures. One fracture required an intramedullary rod to stabilize the femur.
Complications secondary to antibiotic therapy and the two-to three-week period of bed rest before reimplantation included two cases of diarrhea in which Clostridium dificile toxin was identified, two antibiotic-related Lieberman et at. and Related Research rashes, a deep venous thrombosis, a pulmonary embolus, and three sacral decubitus ulcers. All resolved after appropriate medical treatment. In addition, a sigmoid volvulus required surgical decompression.
The complications after reimplantation included one postoperative dislocation, which was successfully treated with a brace for two months, and three nonunions of the greater trochanter (20%), including one with proximal migration. None of these three hips have dislocated.
DISCUSSION
This study retrospectively reviewed patients with infected THAs who were started on a protocol that included resection arthroplasty, followed by six weeks of quantitatively standardized intravenous antibiotics, with possible future reimplantation of a THA. There were 46 hips in this study that were infected and 32 (70%) THAs were actually reimplanted. Of the 32 hips that were reimplanted, there were three recurrent infections (9%), which is consistent with prior reports in the literature.
Although previous report^^,^^,'^,'^,'^ in . the literature have demonstrated that an infected THA can be effectively treated with a twostage reimplantation protocol, the appropriate interval between resection arthroplasty and reimplantation and the duration of antibiotic therapy has not been clearly established. The duration of antibiotic therapy in these studies varied from three to six weeks. 5,6,10,12,14 R ecently, McDonald et a1. ' have advocated the use of more than four weeks of intravenous antibiotics, and delayed reimplantation for at least a year, when there was a "virulent" organism present (gramnegative bacillus or Enterucoccus).
In 24 of 32 cases (75%) in this study, the hip was reimplanted approximately two months after resection arthroplasty. The reimplantation was delayed in the other cases because of the inability to control the infection or at the discretion of the surgeon. Two of these hips ended up with recurrent infections, even though reimplantation was de-layed for five and 32 months respectively. This suggests that simply delaying the reimplantation does not prevent recurrence.
In this series, 29 of the 32 (90%) reimplanted hips received a full six-week course of intravenous antibiotics. Only two patients received four weeks of antibiotics and one received only 20 days. There were no recurrent infections in three patients. The postpeak SBTs attained in these patients were 1: 16, 1 :5 12, and 1 :2048 respectively. This suggests that in the presence of highly sensitive bacteria a shorter course of intravenous antibiotics may be effective.
Recently, McDonald et a1.' recommended delayed reimplantation for a THA infected with a gram-negative organism. During the past 15 years, the authors have obtained minimum bactericidal concentrations (MBC) and postpeak SBTs to help determine if an infected THA should be considered for reimplantation. A postpeak SBT of at least 1:8 was necessary to consider reimplantation. In this study, a minimum postpeak SBT of 1:8 was achieved against all gram-positive organisms, except two enterococcal isolates. A 1 :8 titer was obtained against 17 of 20 gramnegative isolates, including both Pseudomonas infections. The relationship of a gramnegative infection with recurrence did not reach statistical significance (p = 0.1 1) perhaps because of the small numbers in this study. However, an inadequate postpeak SBT was noted to be statistically significant and more common in patients who had a recurrent infection (p = 0.035).
There are a variety of factors that contribute to the successful treatment of the infected THA. These include the quality of the soft tissue, the adequacy of the bone stock, the overall medical condition of the patient, and the antibiotic resistance of the infecting organism. The postpeak SBT is one of the key prognostic factors in determining probable success of a reimplantation. The MBC shows the potential ability of the antibiotic to kill the organism, but it is the postpeak SBT that reflects the antibiotic concentration actually delivered to the blood stream. It may also show any synergistic effects that occur when multiple antibiotics are being used to treat an infection. Thus, the data suggest that the susceptibility of an organism should be determined by the MBC and the postpeak SBT that is attained, and not just by the culture results. The success of the antibiotic therapy is dependent on the MBC and SBT obtained rather than on the identity of the organism. Gram-negative organisms may be exquisitely sensitive to antibiotics and even bacteria of the same species can have variable sensitivities. A gram-negative infection may not be virulent; and thus, an extended delay in reimplantation may not be necessary.
Several authors have reported that small amounts of retained cement did not adversely influence wound healing after resection arthropla~ty.~-~,',~,' Ho wever, McDonald et ~1 .~ have reported that retained cement increased the likelihood of having a recurrent infection after reimplantation. There had been a general belief at the authors' institution that all cement should be removed. In attempting to do so, there were four femoral perforations and two femoral fractures in this study. There were ten cases in which retained cement was present after the resection arthroplasty. There were no recurrent infections in any of these patients, including the seven patients in which the hip was reimplanted. Hunter and Dandy' have suggested that a thorough debridement and proper antibiotic therapy is more important than removal of all retained cement for adequate wound healing in the resection arthroplasty.
Although the data suggest that one may retain cement without the risk of recurrence, an attempt to remove all cement should be made unless there is a serious risk of compromising bone stock that could jeopardize future reimplantation.
One factor that may discourage a surgeon from performing a reimplantation is the necessity of a structural allograft to create a stable acetabulum. Schutzer and Harris" have demonstrated an increased infection rate in THA in cases where large bulk allografts were required. Recently, Berry et al.'
reported an 1 1 % recurrence rate in 18 infected THAs that had two-stage reimplantation with allograft bone. Only two of these hips were infected with a gram-negative organism and one had a recurrent infection. In the present study, five hips were reimplanted with a bulk acetabular allograft after the completion of six weeks of intravenous antibiotics and an adequate postpeak SBT level, without recurrence of infection.
Once a decision has been made to remove the total hip prosthesis, the key elements in eradicating the infection are thorough debridement and effective antibiotic therapy. The infecting organisms must be identified and the quantitative antibiotic susceptibilities obtained. The selection of the appropriate antibiotics and the proper dose should be based on the culture results, the MBC, and the postpeak SBTs. The antibiotic dose may require frequent adjustment until appropriate levels are reached. Close collaboration with an infectious disease consultant is mandatory. A postpeak SBT of at least 1:s should be obtained for each organism that infects the hip. Reimplantation is not recommended if the appropriate antibiotic levels can not be attained.
Although this study includes a limited number of patients, the results of the twostage treatment protocol are encouraging. The data suggest that adequate postpeak SBTs are an important element in successfully treating the patient with an infected THA. However, a larger prospective series will be required to determine the relative importance of quantitative antibiotic titers, duration of antibiotic therapy, and the interval between resection arthroplasty and reimplantation in the treatment of the infected THA. The authors are currently investigating whether a shorter period of intravenous antibiotic therapy can be as effective in infections caused by extremely sensitive bacteria in which postpeak SBTs more than 1: 128 are attained.
